10-Q: XWELL Inc. Q2 2026: Airport Business Sale, Financing, and Net Loss

XWELL, Inc. reported a net loss for Q2 2026, announced the sale of its airport operations, and detailed a significant private placement of Series H Convertible Preferred Stock.

Summary

• XWELL, Inc. reported a net loss of $2.24 million for the three months ended June 30, 2026, and $13.44 million for the six months ended June 30, 2026.
• Total revenue for the three months ended June 30, 2026, was $7.145 million, a decrease of 7% compared to the prior year, primarily due to the cessation of HyperPointe operations.
• Cost of sales decreased by 29% to $4.197 million for the three months ended June 30, 2026, largely due to the absence of HyperPointe costs and reduced labor.
• General and administrative expenses increased by $370,000 to $4.65 million for the three months ended June 30, 2026, driven by legal expenses related to the proposed sale of airport operations.
• The company completed a private placement of Series H Convertible Preferred Stock and warrants in February 2026, raising approximately $31.3 million in gross proceeds.
• A significant strategic development is the July 6, 2026, agreement to sell substantially all airport-based operations (XpresSpa and XpresTest) for approximately $13 million, expected to close in Q4 2026.
• The company reported material weaknesses in internal control over financial reporting, including issues with lease accounting, financial close processes, and revenue recognition.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to continued net losses, significant operating expenses, and the ongoing strategic shift involving the sale of core airport operations, despite recent financing.

Positives

• The company secured $28.269 million in net proceeds from the February 2026 Private Placement of Series H Convertible Preferred Stock and warrants.
• The sale of airport-based operations (XpresSpa and XpresTest) for $13 million is expected to streamline operations and focus the company on non-airport wellness businesses.
• Cost of sales decreased significantly by 29% for the three months ended June 30, 2026, due to the cessation of HyperPointe operations and reduced labor costs.
• Working capital improved to a surplus of $8.471 million as of June 30, 2026, compared to a deficit of $6.982 million as of December 31, 2025.

Negatives

• The company reported a net loss of $2.24 million for the three months ended June 30, 2026, and $13.44 million for the six months ended June 30, 2026.
• Total revenue decreased by 7% to $7.145 million for the three months ended June 30, 2026, primarily due to the cessation of HyperPointe operations.
• General and administrative expenses increased by $370,000 to $4.65 million for the three months ended June 30, 2026, largely due to increased legal expenses related to the proposed sale.
• The company identified multiple material weaknesses in its internal control over financial reporting, impacting lease accounting, financial close, revenue recognition, and foreign subsidiary controls.
• The company has a history of recurring losses and negative cash flows from operations, although management believes it has sufficient liquidity for the next twelve months.

Risks

• The proposed sale of airport-based operations is subject to customary closing conditions, including stockholder approval, and may not be completed.
• The company may not be able to raise sufficient additional capital in the future, which could require tailoring business and operations.
• Ongoing global conflicts and geopolitical instability could adversely impact economic conditions and market volatility, affecting the business.
• The number of airline travelers is volatile and subject to change, impacting the demand for airport-based services.
• Changes in U.S. policy and economic conditions could adversely affect the business.
• The company's ability to operate depends on travelers' propensity for health and wellness services, which can be influenced by various economic factors.

Future Outlook

The company believes it has sufficient liquidity to fund its operations and meet its obligations for at least the next twelve months, supported by recent financing and strategic initiatives. However, future capital needs and the success of the proposed sale of airport operations remain key factors.

Management Comments

• Management is implementing various strategic initiatives to reduce operating expenses, improve working capital and enhance cash flow.
• The company continues to focus on managing operating expenses, optimizing working capital, and improving cash flows from operations.
• The proposed transaction represents a significant strategic shift for the Company and is intended to streamline operations and increase the Company's focus on its non-airport wellness businesses.

Industry Context

StockSavvy.ai notes that XWELL's strategic shift away from airport-based operations towards non-airport wellness services aligns with a broader trend of companies seeking to streamline their business models and focus on core competencies, especially in sectors impacted by volatile travel demand.

Comparison to Industry Standards

• The company's net loss of $13.44 million for the first six months of 2026, coupled with a revenue decline, indicates performance below industry averages for profitable wellness or service-based companies.
• The significant increase in general and administrative expenses, particularly legal costs related to the sale, is a notable deviation from efficient operational spending seen in more stable industry players.
• The reliance on private placements for liquidity, while common for early-stage or turnaround companies, contrasts with established industry leaders who may access public markets or generate sufficient operating cash flow.

Management Changes

Corporate Governance

Legal Proceedings

• The company was awarded approximately $118,000 in an arbitration proceeding related to airport spa operations in Atlanta, with the award confirmed by the Superior Court of Fulton County on July 30, 2026. The deadline to seek appellate review is September 3, 2026.
• The company is involved in various other claims and legal actions arising in the ordinary course of business, which management does not believe will have a material adverse effect.

Related Party Transactions

• Consulting agreement with XWEL INV I, LLC (managed by Jason Aintabi, a >5% beneficial owner) for advisory services, with total payments of $780,000 for the period through January 1, 2026, and an additional $500,000 for a three-month extension. $582,000 was recognized in G&A expenses for the six months ended June 30, 2026.

Stakeholder Impact

• Shareholders: The proposed sale of airport operations and continued net losses may impact share price. The private placement dilutes existing shareholders.
• Creditors: The company's improved working capital and recent financing may provide some comfort, but ongoing losses remain a concern.
• Employees: The sale of airport operations could lead to workforce reductions or changes in employment terms for affected employees.
• Suppliers: The strategic shift and potential divestiture may impact existing supplier relationships.

Next Steps

• Obtain stockholder approval for the sale of airport-based operations.
• Complete the sale of XpresSpa and XpresTest operations, expected in Q4 2026.
• Focus on non-airport wellness businesses following the divestiture.
• Continue implementing strategic initiatives to reduce operating expenses and improve cash flow.
• Remediate material weaknesses in internal control over financial reporting.

Key Dates

Recommendation

The company is undergoing a significant strategic transformation with the sale of its core airport operations, which introduces considerable uncertainty. While recent financing has improved liquidity, the persistent net losses and identified material weaknesses in internal controls present substantial risks. The outcome of the asset sale and the company's ability to achieve profitability in its remaining non-airport businesses are critical factors that warrant a cautious 'hold' stance until more clarity emerges.

Keywords

XWELL, Quarterly Report, Form 10-Q, Financial Statements, Revenue, Net Loss, Private Placement, Asset Sale